Journal: Proceedings of the National Academy of Sciences of the United States of America
Article Title: ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1.
doi: 10.1073/pnas.2210418120
Figure Lengend Snippet: Fig. 6. ABL kinases protect HIF-1α from CPSF1-dependent degradation. (A) IB analysis of WCL derived from HEK293T and PC9 cells transduced with indicated gRNA/CRISPR- Cas9 constructs and then treated with ABL001 during hypoxia for 24 h. (B) IB analysis of WCL derived from HEK293T cells transfected with 3xFlag-HIF1A, ABL1-eGFP, and HA-CPSF1 constructs for 24 h and then exposed to hypoxia for 24 h. (C) IB and IP analysis of WCL derived from PC9 cells treated with ABL001 (24 h) and MG132 (final 6 h) during hypoxia for 24 h. IgG sample added to the vehicle and MG132-treated lysate. (D) Proposed model depicting loss of ABL kinase activity leading to CPSF1-dependent HIF-1α ubiquitination and proteasome-mediated protein degradation.
Article Snippet: The following primary antibodies were used for IB analyses: ABL1 (Sigma MAB1130 1:1,000), ABL2 (Abnova, H00000027-M03, 1:500), ACTIN (Cell Signaling 3700 1:10,000), CPSF1 (Bethyl A301-580A 1:1,000), CRKL (Santa Cruz sc-319 1:1,000), CRKL p-Y207 (Cell Signaling 3181 1:500), Flag (Sigma M2 1:5,000), GFP (Cell Signaling 2956 1:1,000), HA (Cell Signaling 2367 1:1,000), HIF-1α (BD Bioscience 610959 1:1,000), HIF-2α (Novus NB100-122 1:1,000), HIF-1β (Novus NB100-124 1:1,000), MYC (Cell Signaling 5605 1:5,000), Ubb (Santa Cruz sc-166553 1:1,000), and p-Y 4G10 (Sigma 05-321).
Techniques: Derivative Assay, Transduction, CRISPR, Construct, Transfection, Activity Assay, Ubiquitin Proteomics